APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Rabies Immunoglobulin (IM)

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Selected research

Industry Research

Human Rabies Immunoglobulin (IM) Industry Research Report 2026

26 December 2025120 pages

Choose your research edition.

Industry ResearchHuman Rabies Immunoglobulin (IM) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Rabies Immunoglobulin (IM) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Human Rabies Immunoglobulin (IM) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Rabies Immunoglobulin (IM) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Rabies Immunoglobulin (IM) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.

Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.

In this report, we study ERIG (Equine Rabies Immunoglobulin) and HRIG (Human Rabies Immunoglobulin)

Read the full market overview

Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China and Europe, both have a share about 45 percent.

In terms of product, HRIG is the largest segment, with a share over 85%. And in terms of application, the largest application is Category III Exposure, followed by Category II Exposure.

Report Scope

This report quantifies the global Human Rabies Immunoglobulin (IM) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Human Rabies Immunoglobulin (IM) Market by Company

CSL Behring

Grifols

Sanofi

Sichuan Yuanda Shuyang

CNBG

Kamada

CBPO

Shuanglin Bio

Weiguang Bio

Shanghai RAAS

Bharat Serum

VINS

Human Rabies Immunoglobulin (IM) Segment by Type

ERIG

HRIG

Human Rabies Immunoglobulin (IM) Segment by Application

Category II Exposure

Category III Exposure

Human Rabies Immunoglobulin (IM) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Rabies Immunoglobulin (IM) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Rabies Immunoglobulin (IM) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Rabies Immunoglobulin (IM).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Human Rabies Immunoglobulin (IM) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Human Rabies Immunoglobulin (IM) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Human Rabies Immunoglobulin (IM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Human Rabies Immunoglobulin (IM) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Human Rabies Immunoglobulin (IM) Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Human Rabies Immunoglobulin (IM) Revenue of Manufacturers (2021-2026) Table 9. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Human Rabies Immunoglobulin (IM) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application Table 14. Global Human Rabies Immunoglobulin (IM) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Human Rabies Immunoglobulin (IM) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CSL Behring Company Information Table 19. CSL Behring Business Overview Table 20. CSL Behring Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio Table 22. CSL Behring Recent Developments Table 23. Grifols Company Information Table 24. Grifols Business Overview Table 25. Grifols Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Grifols Human Rabies Immunoglobulin (IM) Product Portfolio Table 27. Grifols Recent Developments Table 28. Sanofi Company Information Table 29. Sanofi Business Overview Table 30. Sanofi Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio Table 32. Sanofi Recent Developments Table 33. Sichuan Yuanda Shuyang Company Information Table 34. Sichuan Yuanda Shuyang Business Overview Table 35. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio Table 37. Sichuan Yuanda Shuyang Recent Developments Table 38. CNBG Company Information Table 39. CNBG Business Overview Table 40. CNBG Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. CNBG Human Rabies Immunoglobulin (IM) Product Portfolio Table 42. CNBG Recent Developments Table 43. Kamada Company Information Table 44. Kamada Business Overview Table 45. Kamada Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Kamada Human Rabies Immunoglobulin (IM) Product Portfolio Table 47. Kamada Recent Developments Table 48. CBPO Company Information Table 49. CBPO Business Overview Table 50. CBPO Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. CBPO Human Rabies Immunoglobulin (IM) Product Portfolio Table 52. CBPO Recent Developments Table 53. Shuanglin Bio Company Information Table 54. Shuanglin Bio Business Overview Table 55. Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio Table 57. Shuanglin Bio Recent Developments Table 58. Weiguang Bio Company Information Table 59. Weiguang Bio Business Overview Table 60. Weiguang Bio Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio Table 62. Weiguang Bio Recent Developments Table 63. Shanghai RAAS Company Information Table 64. Shanghai RAAS Business Overview Table 65. Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio Table 67. Shanghai RAAS Recent Developments Table 68. Bharat Serum Company Information Table 69. Bharat Serum Business Overview Table 70. Bharat Serum Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio Table 72. Bharat Serum Recent Developments Table 73. VINS Company Information Table 74. VINS Business Overview Table 75. VINS Human Rabies Immunoglobulin (IM) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. VINS Human Rabies Immunoglobulin (IM) Product Portfolio Table 77. VINS Recent Developments Table 78. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Human Rabies Immunoglobulin (IM) Sales by Region (2021-2026) & (K Units) Table 80. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2021-2026) Table 81. Global Human Rabies Immunoglobulin (IM) Sales by Region (2027-2032) & (K Units) Table 82. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Region (2027-2032) Table 83. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2021-2026) Table 85. Global Human Rabies Immunoglobulin (IM) Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Region (2027-2032) Table 87. North America Human Rabies Immunoglobulin (IM) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 89. North America Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 90. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Human Rabies Immunoglobulin (IM) Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Human Rabies Immunoglobulin (IM) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 94. Europe Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 95. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Human Rabies Immunoglobulin (IM) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 104. South America Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 105. South America Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Human Rabies Immunoglobulin (IM) Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Human Rabies Immunoglobulin (IM) Sales by Type (2021-2026) & (K Units) Table 113. Global Human Rabies Immunoglobulin (IM) Sales by Type (2027-2032) & (K Units) Table 114. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2021-2026) Table 115. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2027-2032) Table 116. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Human Rabies Immunoglobulin (IM) Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2021-2026) Table 119. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2027-2032) Table 120. Global Human Rabies Immunoglobulin (IM) Price by Type (2021-2026) & (USD/Unit) Table 121. Global Human Rabies Immunoglobulin (IM) Price by Type (2027-2032) & (USD/Unit) Table 122. Global Human Rabies Immunoglobulin (IM) Sales by Application (2021-2026) & (K Units) Table 123. Global Human Rabies Immunoglobulin (IM) Sales by Application (2027-2032) & (K Units) Table 124. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2021-2026) Table 125. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2027-2032) Table 126. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Human Rabies Immunoglobulin (IM) Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2021-2026) Table 129. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2027-2032) Table 130. Global Human Rabies Immunoglobulin (IM) Price by Application (2021-2026) & (USD/Unit) Table 131. Global Human Rabies Immunoglobulin (IM) Price by Application (2027-2032) & (USD/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Human Rabies Immunoglobulin (IM) Distributors List Table 135. Human Rabies Immunoglobulin (IM) Customers List Table 136. Human Rabies Immunoglobulin (IM) Industry Trends Table 137. Human Rabies Immunoglobulin (IM) Industry Drivers Table 138. Human Rabies Immunoglobulin (IM) Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Human Rabies Immunoglobulin (IM) Product Image Figure 5. Global Human Rabies Immunoglobulin (IM) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Human Rabies Immunoglobulin (IM) Market Size (2021-2032) & (US$ Million) Figure 7. Global Human Rabies Immunoglobulin (IM) Sales (2021-2032) & (K Units) Figure 8. Global Human Rabies Immunoglobulin (IM) Average Price (USD/Unit) & (2021-2032) Figure 9. ERIG Product Image Figure 10. HRIG Product Image Figure 11. Category II Exposure Product Image Figure 12. Category III Exposure Product Image Figure 13. Global Human Rabies Immunoglobulin (IM) Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Human Rabies Immunoglobulin (IM) Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Human Rabies Immunoglobulin (IM) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Human Rabies Immunoglobulin (IM) Sales by Region in 2025 Figure 19. Global Human Rabies Immunoglobulin (IM) Revenue by Region in 2025 Figure 20. North America Human Rabies Immunoglobulin (IM) Market Size by Country in 2025 Figure 21. North America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2021-2032) Figure 22. North America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2021-2032) Figure 23. United States Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Human Rabies Immunoglobulin (IM) Market Size by Country in 2025 Figure 27. Europe Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2021-2032) Figure 28. Europe Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2021-2032) Figure 29. Germany Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Country in 2025 Figure 40. Asia Pacific Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2021-2032) Figure 42. China Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Human Rabies Immunoglobulin (IM) Market Size by Country in 2025 Figure 51. South America Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2021-2032) Figure 52. South America Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2021-2032) Figure 53. Brazil Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Country in 2025 Figure 57. Middle East and Africa Human Rabies Immunoglobulin (IM) Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue Market Share by Country (2021-2032) Figure 59. Egypt Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Human Rabies Immunoglobulin (IM) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2021-2032) Figure 65. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2021-2032) Figure 66. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Type (2021-2032) Figure 67. Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2021-2032) Figure 68. Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2021-2032) Figure 69. Global Human Rabies Immunoglobulin (IM) Price (USD/Unit) by Application (2021-2032) Figure 70. Human Rabies Immunoglobulin (IM) Value Chain Figure 71. Human Rabies Immunoglobulin (IM) Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Human Rabies Immunoglobulin (IM) Industry Opportunities and Challenges

Scope & coverage.

Types
  • ERIG
  • HRIG
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • CSL Behring
  • Grifols
  • Sanofi
  • Sichuan Yuanda Shuyang
  • CNBG
  • Kamada
  • CBPO
  • Shuanglin Bio
  • Weiguang Bio
  • Shanghai RAAS
  • Bharat Serum
  • VINS

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Human Rabies Immunoglobulin (IM) Market Size (2021-2032)
  4. 2.2.2 Global Human Rabies Immunoglobulin (IM) Sales (2021-2032)
  5. 2.2.3 Global Human Rabies Immunoglobulin (IM) Market Average Price (2021-2032)
  6. 2.3 Human Rabies Immunoglobulin (IM) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 ERIG
  9. 2.3.3 HRIG
  10. 2.4 Human Rabies Immunoglobulin (IM) by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Category II Exposure
  13. 2.4.3 Category III Exposure
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Human Rabies Immunoglobulin (IM) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Human Rabies Immunoglobulin (IM) Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Human Rabies Immunoglobulin (IM) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Human Rabies Immunoglobulin (IM) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Human Rabies Immunoglobulin (IM) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Human Rabies Immunoglobulin (IM), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Human Rabies Immunoglobulin (IM), Product Type & Application
  8. 3.8 Global Manufacturers of Human Rabies Immunoglobulin (IM), Established Date
  9. 3.9 Global Human Rabies Immunoglobulin (IM) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CSL Behring
  2. 4.1.1 CSL Behring Company Information
  3. 4.1.2 CSL Behring Business Overview
  4. 4.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CSL Behring Human Rabies Immunoglobulin (IM) Product Portfolio
  6. 4.1.5 CSL Behring Recent Developments
  7. 4.2 Grifols
  8. 4.2.1 Grifols Company Information
  9. 4.2.2 Grifols Business Overview
  10. 4.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Grifols Human Rabies Immunoglobulin (IM) Product Portfolio
  12. 4.2.5 Grifols Recent Developments
  13. 4.3 Sanofi
  14. 4.3.1 Sanofi Company Information
  15. 4.3.2 Sanofi Business Overview
  16. 4.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sanofi Human Rabies Immunoglobulin (IM) Product Portfolio
  18. 4.3.5 Sanofi Recent Developments
  19. 4.4 Sichuan Yuanda Shuyang
  20. 4.4.1 Sichuan Yuanda Shuyang Company Information
  21. 4.4.2 Sichuan Yuanda Shuyang Business Overview
  22. 4.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Product Portfolio
  24. 4.4.5 Sichuan Yuanda Shuyang Recent Developments
  25. 4.5 CNBG
  26. 4.5.1 CNBG Company Information
  27. 4.5.2 CNBG Business Overview
  28. 4.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CNBG Human Rabies Immunoglobulin (IM) Product Portfolio
  30. 4.5.5 CNBG Recent Developments
  31. 4.6 Kamada
  32. 4.6.1 Kamada Company Information
  33. 4.6.2 Kamada Business Overview
  34. 4.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Kamada Human Rabies Immunoglobulin (IM) Product Portfolio
  36. 4.6.5 Kamada Recent Developments
  37. 4.7 CBPO
  38. 4.7.1 CBPO Company Information
  39. 4.7.2 CBPO Business Overview
  40. 4.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 CBPO Human Rabies Immunoglobulin (IM) Product Portfolio
  42. 4.7.5 CBPO Recent Developments
  43. 4.8 Shuanglin Bio
  44. 4.8.1 Shuanglin Bio Company Information
  45. 4.8.2 Shuanglin Bio Business Overview
  46. 4.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Shuanglin Bio Human Rabies Immunoglobulin (IM) Product Portfolio
  48. 4.8.5 Shuanglin Bio Recent Developments
  49. 4.9 Weiguang Bio
  50. 4.9.1 Weiguang Bio Company Information
  51. 4.9.2 Weiguang Bio Business Overview
  52. 4.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Weiguang Bio Human Rabies Immunoglobulin (IM) Product Portfolio
  54. 4.9.5 Weiguang Bio Recent Developments
  55. 4.10 Shanghai RAAS
  56. 4.10.1 Shanghai RAAS Company Information
  57. 4.10.2 Shanghai RAAS Business Overview
  58. 4.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Shanghai RAAS Human Rabies Immunoglobulin (IM) Product Portfolio
  60. 4.10.5 Shanghai RAAS Recent Developments
  61. 4.11 Bharat Serum
  62. 4.11.1 Bharat Serum Company Information
  63. 4.11.2 Bharat Serum Business Overview
  64. 4.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Bharat Serum Human Rabies Immunoglobulin (IM) Product Portfolio
  66. 4.11.5 Bharat Serum Recent Developments
  67. 4.12 VINS
  68. 4.12.1 VINS Company Information
  69. 4.12.2 VINS Business Overview
  70. 4.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 VINS Human Rabies Immunoglobulin (IM) Product Portfolio
  72. 4.12.5 VINS Recent Developments
5 Global Human Rabies Immunoglobulin (IM) Market Scenario by Region
  1. 5.1 Global Human Rabies Immunoglobulin (IM) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2021-2032
  3. 5.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2021-2026
  4. 5.2.2 Global Human Rabies Immunoglobulin (IM) Sales by Region: 2027-2032
  5. 5.3 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2021-2032
  6. 5.3.1 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2021-2026
  7. 5.3.2 Global Human Rabies Immunoglobulin (IM) Revenue by Region: 2027-2032
  8. 5.4 North America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
  9. 5.4.1 North America Human Rabies Immunoglobulin (IM) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Human Rabies Immunoglobulin (IM) Sales by Country (2021-2032)
  11. 5.4.3 North America Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
  16. 5.5.1 Europe Human Rabies Immunoglobulin (IM) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Human Rabies Immunoglobulin (IM) Sales by Country (2021-2032)
  18. 5.5.3 Europe Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Human Rabies Immunoglobulin (IM) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Human Rabies Immunoglobulin (IM) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
  41. 5.7.1 South America Human Rabies Immunoglobulin (IM) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Human Rabies Immunoglobulin (IM) Sales by Country (2021-2032)
  43. 5.7.3 South America Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032)
  2. 6.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Human Rabies Immunoglobulin (IM) Revenue by Type (2021-2032)
  5. 6.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Human Rabies Immunoglobulin (IM) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032)
  2. 7.1.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Human Rabies Immunoglobulin (IM) Revenue by Application (2021-2032)
  5. 7.2.1 Global Human Rabies Immunoglobulin (IM) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Human Rabies Immunoglobulin (IM) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Human Rabies Immunoglobulin (IM) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Human Rabies Immunoglobulin (IM) Value Chain Analysis
  2. 8.1.1 Human Rabies Immunoglobulin (IM) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Human Rabies Immunoglobulin (IM) Production Mode & Process
  5. 8.2 Human Rabies Immunoglobulin (IM) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Human Rabies Immunoglobulin (IM) Distributors
  8. 8.2.3 Human Rabies Immunoglobulin (IM) Customers
9 Global Human Rabies Immunoglobulin (IM) Analyzing Market Dynamics
  1. 9.1 Human Rabies Immunoglobulin (IM) Industry Trends
  2. 9.2 Human Rabies Immunoglobulin (IM) Industry Drivers
  3. 9.3 Human Rabies Immunoglobulin (IM) Industry Opportunities and Challenges
  4. 9.4 Human Rabies Immunoglobulin (IM) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst